Basic Principles of Drug Discovery and Development,

Edition 3

Editors: By Benjamin E. Blass

Publication Date: 06 Mar 2026

0 Reviews

Awaiting publication

Conformance

PDF/UA-1
The publication contains a conformance statement that it meets the EPUB Accessibility 1.1, WCAG 2.1, Level AA standard. Please see https://bornaccessible.benetech.org/certified-publishers/ for further details of our compatibility testing.
The publication was certified on 20250728
Accessibility addendum
The certifier's credential is https://bornaccessible.benetech.org/certified-publishers/
For detailed accessibility information, see Elsevier’s website at https://www.elsevier.com/about/accessibility
Compatibility tested
For queries regarding accessibility information, contact [email protected]

Ways Of Reading

This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation.
All contents of the digital publication necessary to use and understanding, including any text, images (via alternative descriptions), video (via audio description) is fully accessible via suitable audio reproduction.

Navigation

The contents of the PDF have been tagged to permit access by assistive technologies as per PDF-UA-1 standard.
Page breaks included from the original print source

Additional Accessibility Information

All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.
For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
Content is enhanced with ARIA roles to optimize organization and facilitate navigation
Where interactive content is included in the product, controls are provided (e.g., for speed, pause and resume, reset) and labelled to make their use clear.

WCAG v2.2

Note

This product relies on 3rd party tooling which may impact the accessibility features visible in inspection copies. All accessibility features mentioned would be present in the purchased version of the title.

Basic Principles of Drug Discovery and Development, Third Edition presents a unique overview of the drug discovery and development program not available elsewhere. Each chapter provides sufficient technical details on the topics covered so that non-experts will have the tools and information necessary to interact and exchange information with colleagues across the entire spectrum of the drug discovery and development process. The drug discovery and development process involves individuals and teams with a wide array of expertise ranging from basic sciences (medicinal chemistry, biology) to applied science (pharmacology, pharmacokinetics, clinical sciences) to business driven fields (regulatory affairs, intellectual property experts, marketing specialists).

The success or failure of a program focused on bringing a new medication to market often depends on clear communication between individuals and teams with vastly different expertise. As a result, it is critical that experts in one aspect of drug discovery and development (e.g., medicinal chemists) have a working understanding of the wide range of disciplines that take part in the overall process.

Key Features

Provides a clear explanation of how the pharmaceutical industry works, as well as the complete drug discovery process, from obtaining a lead, to testing the bioactivity, to producing the drug, and protecting the intellectual property
Includes a new chapter on the discovery and development of biologics (antibodies proteins, antibody/receptor complexes, antibody drug conjugates), a growing and important area of the pharmaceutical industry landscape
Features a new section on formulations, including a discussion of IV formulations suitable for human clinical trials, as well as the application of nanotechnology and the use of transdermal patch technology for drug delivery
Includes new case studies with additional modern examples of drug discovery using high through-put screening, fragment-based drug design, and computational chemistry, as well as studies on the development of biologics

About the author

By Benjamin E. Blass, Temple University School of Pharmacy, Philadelphia, PA, USA

1. An overview of drug discovery process
2. A history of drug discovery
3. Biological targets in drug discovery
4. In Vitro Screening Systems
5. Medicinal Chemistry in Drug Discovery
6. Pharmacokinetics: Basic ADMET Principles
7. Animal Models of Disease States
8. Safety and Toxicology
9. Biotherapeutics drug discovery
10. Vaccine Discovery and Development
11. Basics of Clinical Trials
12. Translational and Experimental Medicine in Drug Discovery
13. Organizational Structures of Biotech Operations
14. Intellectual Property and Patents in Drug
15. Case studies in drug discovery

ISBN: 9780443157479

Page Count: 830

Retail Price :

Graduate students/upper-level undergraduates/graduate students interested in drug discovery research, chemistry, biology, pharmacology, biochemistry, toxicology, formulations, discovery/development of new therapeutic agents, pharmaceutical industry